$268 Million is the total value of Endurant Capital Management LP's 69 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DRNA | Exit | DICERNA PHARMACEUTICALS INC | $0 | – | -18,837 | -100.0% | -0.05% | – |
| BHVN | Exit | BIOHAVEN PHARMACTL HLDG CO L | $0 | – | -10,300 | -100.0% | -0.08% | – |
| SPRO | Exit | SPERO THERAPEUTICS INC | $0 | – | -31,100 | -100.0% | -0.11% | – |
| APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -17,600 | -100.0% | -0.12% | – |
| ASMB | Exit | ASSEMBLY BIOSCIENCES INC | $0 | – | -9,500 | -100.0% | -0.13% | – |
| OMED | Exit | ONCOMED PHARMACEUTICALS INC | $0 | – | -139,100 | -100.0% | -0.17% | – |
| INSM | Exit | INSMED INC | $0 | – | -22,910 | -100.0% | -0.22% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -10,100 | -100.0% | -0.28% | – |
| VCRA | Exit | VOCERA COMMUNICATIONS INC | $0 | – | -32,500 | -100.0% | -0.30% | – |
| IMGN | Exit | IMMUNOGEN INC | $0 | – | -210,800 | -100.0% | -0.41% | – |
| EW | Exit | EDWARDS LIFESCIENCES CORP | $0 | – | -12,216 | -100.0% | -0.42% | – |
| TCMD | Exit | TACTILE SYS TECHNOLOGY INC | $0 | – | -50,900 | -100.0% | -0.45% | – |
| ASND | Exit | ASCENDIS PHARMA A Ssponsored adr | $0 | – | -37,828 | -100.0% | -0.46% | – |
| ARA | Exit | AMERICAN RENAL ASSOCIATES HO | $0 | – | -89,129 | -100.0% | -0.47% | – |
| HUM | Exit | HUMANA INC | $0 | – | -6,800 | -100.0% | -0.52% | – |
| MEDP | Exit | MEDPACE HLDGS INC | $0 | – | -63,100 | -100.0% | -0.70% | – |
| AERI | Exit | AERIE PHARMACEUTICALS INC | $0 | – | -45,366 | -100.0% | -0.83% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -48,800 | -100.0% | -0.83% | – |
| SYK | Exit | STRYKER CORP | $0 | – | -17,867 | -100.0% | -0.85% | – |
| ENTL | Exit | ENTELLUS MED INC | $0 | – | -189,268 | -100.0% | -1.41% | – |
| BIIB | Exit | BIOGEN INC | $0 | – | -15,399 | -100.0% | -1.50% | – |
| INCR | Exit | INC RESH HLDGS INCcl a | $0 | – | -112,900 | -100.0% | -1.50% | – |
| ABC | Exit | AMERISOURCEBERGEN CORP | $0 | – | -55,240 | -100.0% | -1.55% | – |
| BBH | Exit | VANECK VECTORS ETF TRbiotech etf | $0 | – | -49,899 | -100.0% | -1.90% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LABORATORY CORP AMER HLDGS | 31 | Q2 2023 | 8.7% |
| ELEVANCE HEALTH INC | 29 | Q3 2023 | 8.8% |
| BECTON DICKINSON & CO | 28 | Q2 2023 | 9.8% |
| MCKESSON CORP | 27 | Q1 2023 | 4.4% |
| CENCORA INC | 26 | Q3 2023 | 5.9% |
| HOLOGIC INC | 24 | Q3 2023 | 7.5% |
| JOHNSON & JOHNSON | 24 | Q4 2021 | 5.5% |
| ZIMMER HLDGS INC | 23 | Q3 2023 | 7.5% |
| BOSTON SCIENTIFIC CORP | 22 | Q3 2023 | 5.5% |
| DAVITA INC | 22 | Q1 2021 | 4.9% |
View Endurant Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AZIYO BIOLOGICS, INC. | March 21, 2023 | 576,253 | 4.9% |
| Oxford Immunotec Global PLCSold out | February 17, 2021 | 0 | 0.0% |
View Endurant Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-07 |
| SC 13D/A | 2024-04-10 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| SC 13D/A | 2023-09-08 |
| 13F-HR | 2023-08-14 |
| 3/A | 2023-05-24 |
| 13F-HR | 2023-05-15 |
| 3 | 2023-05-15 |
| SC 13D | 2023-05-15 |
View Endurant Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.